{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["breast cancer", "chlorogenic acid", "estrogen receptor", "hesperidin", "synergistic effect"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34575098", "DateRevised": {"Year": "2021", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "10"}], "Language": ["eng"], "ELocationID": ["950", "10.3390/life11090950"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "11", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "10"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Hesperidin and Chlorogenic Acid Synergistically Inhibit the Growth of Breast Cancer Cells via Estrogen Receptor/Mitochondrial Pathway.", "Abstract": {"AbstractText": ["Breast cancer is the most common cancer in women worldwide. Hesperidin (Hes) and chlorogenic acid (CA) are traditional medicinal molecules that abundantly exist in natural plants or foods. These compounds have been shown to prevent and suppress various cancers and therefore can be utilized as adjunctive therapies to aid cancer treatment. Here, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays show a greater synergistic inhibitory effect on the growth of breast cancer cells, MCF-7, but not normal breast cells, MCF-10A, than hesperidin or chlorogenic acid alone. We present the possible molecular signaling pathways in MCF-7 cells with or without herbal molecule treatments via proteomic approaches. The data were further analyzed by Ingenuity Pathway Analysis (IPA) and confirmed by quantifying mRNA associated with the estrogen-receptor signaling pathway and mitochondrial functions. We demonstrated that the expression of CYC1, TFAM, ATP5PB, mtATP6, mtDNA, and NRF-1 were decreased upon 12 h treatment, and subsequent ATP production was also significantly decreased at 24 h. These results identified a synergistic effect induced by combinational treatment with hesperidin and chlorogenic acid, which can regulate mitochondria and ATP production through the estrogen receptor pathway in MCF-7 cells. However, none of the treatments induced the generation of reactive oxygen species (ROS), suggesting that ROS likely plays no role in the observed pharmacological activities. Overall, our study sheds light on the adequacy of hesperidin and chlorogenic acid to serve as an adjunctive therapy when co-administrated with chemotherapy drugs in breast cancer patients."]}, "AuthorList": [{"Identifier": ["0000-0001-6873-6434"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioscience and Biotechnology, College of Life Sciences, National Taiwan Ocean University, No. 2, Beining Rd, Zhongzheng District, Keelung City 202, Taiwan."}, {"Identifier": [], "Affiliation": "Center of Excellence for the Oceans, National Taiwan Ocean University, No. 2, Beining Rd, Zhongzheng District, Keelung City 202, Taiwan."}, {"Identifier": [], "Affiliation": "Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, No. 155, Section 2, Linong St, Beitou District, Taipei City 112, Taiwan."}], "LastName": "Hsu", "ForeName": "Pang-Hung", "Initials": "PH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioscience and Biotechnology, College of Life Sciences, National Taiwan Ocean University, No. 2, Beining Rd, Zhongzheng District, Keelung City 202, Taiwan."}], "LastName": "Chen", "ForeName": "Wei-Hsuan", "Initials": "WH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Food Science and Technology, National Taiwan University, No. 1, Roosevelt Rd, Da'an District, Taipei City 10617, Taiwan."}], "LastName": "Juan-Lu", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Food Science and Technology, National Taiwan University, No. 1, Roosevelt Rd, Da'an District, Taipei City 10617, Taiwan."}], "LastName": "Hsieh", "ForeName": "Shu-Chen", "Initials": "SC"}, {"Identifier": ["0000-0003-2942-5937"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bachelor Degree Program in Marine Biotechnology, College of Life Sciences, National Taiwan Ocean University, No. 2, Beining Rd, Zhongzheng District, Keelung City 202, Taiwan."}], "LastName": "Lin", "ForeName": "Shih-Chao", "Initials": "SC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science & Technology, National Yang Ming Chiao Tung University, No. 75, Boai Street, Hsinchu 300, Taiwan."}], "LastName": "Mai", "ForeName": "Ru-Tsun", "Initials": "RT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioscience and Biotechnology, College of Life Sciences, National Taiwan Ocean University, No. 2, Beining Rd, Zhongzheng District, Keelung City 202, Taiwan."}], "LastName": "Chen", "ForeName": "Shiow-Yi", "Initials": "SY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Huang Y.-C., Chen Y.-H. Cancer incidence characteristic evolution based on the National Cancer Registry in Taiwan. J. Oncol. 2020;2020:1408793. doi: 10.1155/2020/1408793.", "ArticleIdList": ["10.1155/2020/1408793", "PMC7396109", "32774368"]}, {"Citation": "Kuo C.-N., Liao Y.-M., Kuo L.-N., Tsai H.-J., Chang W.-C., Yen Y. Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost. J. Formos. Med. Assoc. 2019;119:1731\u20131741. doi: 10.1016/j.jfma.2019.08.023.", "ArticleIdList": ["10.1016/j.jfma.2019.08.023", "31522970"]}, {"Citation": "Cheng S.H., Tsou M.H., Liu M.C., Jian J.J., Cheng J.C.H., Leu S.Y., Hsieh C.-Y., Huang A.T. Unique features of breast cancer in Taiwan. Breast Cancer Res. Treat. 2000;63:213\u2013223. doi: 10.1023/A:1006468514396.", "ArticleIdList": ["10.1023/A:1006468514396", "11110055"]}, {"Citation": "Ministry of Health and Welfare, Taiwan (R.O.C.)  2020 Statistics of Causes of Death.  [(accessed on 30 August 2021)];2018  Available online:  https://dep.mohw.gov.tw/dos/lp-5069-113-xCat-y109.html."}, {"Citation": "Trayes K.P., Cokenakes S.E.H. Breast cancer treatment. Am. Fam. Phys. 2021;104:171\u2013178.", "ArticleIdList": ["34383430"]}, {"Citation": "Fisusi F.A., Akala E.O. Drug combinations in breast cancer therapy. Pharm. Nanotechnol. 2019;7:3\u201323. doi: 10.2174/2211738507666190122111224.", "ArticleIdList": ["10.2174/2211738507666190122111224", "PMC6691849", "30666921"]}, {"Citation": "Silvestri M., Cristaudo A., Morrone A., Messina C., Bennardo L., Nistic\u00f2 S.P., Mariano M., Cameli N. Emerging skin toxicities in patients with breast cancer treated with new cyclin-dependent kinase 4/6 inhibitors: A systematic review. Drug Saf. 2021;44:725\u2013732. doi: 10.1007/s40264-021-01071-1.", "ArticleIdList": ["10.1007/s40264-021-01071-1", "33959899"]}, {"Citation": "Kim W., Lee W.-B., Lee J.-W., Min B.-I., Baek S.K., Lee H., Cho S.-H. Traditional herbal medicine as adjunctive therapy for breast cancer: A systematic review. Complement. Ther. Med. 2015;23:626\u2013632. doi: 10.1016/j.ctim.2015.03.011.", "ArticleIdList": ["10.1016/j.ctim.2015.03.011", "26275657"]}, {"Citation": "Schr\u00f6der S., Beckmann K., Franconi G., Meyer-Hamme G., Friedemann T., Greten H.J., Rostock M., Efferth T. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemothera-py-induced peripheral neuropathy? Evid.-Based Complement Alternat. Med. 2013;2013:423713. doi: 10.1155/2013/423713.", "ArticleIdList": ["10.1155/2013/423713", "PMC3747437", "23983777"]}, {"Citation": "Li W., Song K., Wang S., Zhang C., Zhuang M., Wang Y., Liu T. Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation. Mater. Sci. Eng. C. 2019;98:685\u2013695. doi: 10.1016/j.msec.2019.01.025.", "ArticleIdList": ["10.1016/j.msec.2019.01.025", "30813073"]}, {"Citation": "Zhou R., Chen H., Chen J., Chen X., Wen Y., Xu L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC Complement. Altern. Med. 2018;18:1\u20138. doi: 10.1186/s12906-018-2148-2.", "ArticleIdList": ["10.1186/s12906-018-2148-2", "PMC5845298", "29523109"]}, {"Citation": "Akiyama S., Katsumata S.-I., Suzuki K., Ishimi Y., Wu J., Uehara M. Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 2009;46:87\u201392. doi: 10.3164/jcbn.09-82.", "ArticleIdList": ["10.3164/jcbn.09-82", "PMC2803138", "20104270"]}, {"Citation": "Yang H.L., Chen S.C., Senthil Kumar K.J., Yu K.N., Lee Chao P.D., Tsai S.Y., Hou Y.C., Hseu Y.C. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: An ex vivo approach. J. Agric. Food. Chem. 2012;60:522\u2013532. doi: 10.1021/jf2040675.", "ArticleIdList": ["10.1021/jf2040675", "22098419"]}, {"Citation": "Middleton E., Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 1992;43:1167\u20131179. doi: 10.1016/0006-2952(92)90489-6.", "ArticleIdList": ["10.1016/0006-2952(92)90489-6", "1562270"]}, {"Citation": "Lee C.J., Wilson L., Jordan M.A., Nguyen V., Tang J., Smiyun G. Hesperidin suppressed proliferations of both Human breast cancer and androgen-dependent prostate cancer cells. Phytother. Res. 2009;24:S15\u2013S19. doi: 10.1002/ptr.2856.", "ArticleIdList": ["10.1002/ptr.2856", "19548283"]}, {"Citation": "Kabala-Dzik A., Rzepecka-Stojko A., Kubina R., Iriti M., Wojtyczka R.D., Buszman E., Stojko J. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7-A comparative study. Cell Mol. Biol. 2018;64:1\u201310. doi: 10.14715/cmb/2018.64.8.1.", "ArticleIdList": ["10.14715/cmb/2018.64.8.1", "29981677"]}, {"Citation": "Upadhyay R., Mohan Rao L.J. An outlook on chlorogenic acids-occurrence, chemistry, technology, and biological activi-ties. Crit. Rev. Food Sci. Nutr. 2013;53:968\u2013984. doi: 10.1080/10408398.2011.576319.", "ArticleIdList": ["10.1080/10408398.2011.576319", "23768188"]}, {"Citation": "Kim C., Yu H.G., Sohn J. The anti-angiogenic effect of chlorogenic acid on choroidal neovascularization. Korean J. Ophthalmol. 2010;24:163\u2013168. doi: 10.3341/kjo.2010.24.3.163.", "ArticleIdList": ["10.3341/kjo.2010.24.3.163", "PMC2882080", "20532143"]}, {"Citation": "Tsang M.S.-M., Jiao D., Chan B.C.L., Hon K.-L., Leung P.C., Lau C.B.S., Wong E.C.W., Cheng L., Chan C.K.M., Lam C.W.K., et al. Anti-inflammatory activities of pentaherbs formula, berberine, gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation. Molecules. 2016;21:519. doi: 10.3390/molecules21040519.", "ArticleIdList": ["10.3390/molecules21040519", "PMC6274171", "27104513"]}, {"Citation": "Deka S.J., Gorai S., Manna D., Trivedi V. Evidence of PKC binding and translocation to explain the anticancer mechanism of chlorogenic acid in breast cancer cells. Curr. Mol. Med. 2017;17:79\u201389. doi: 10.2174/1566524017666170209160619.", "ArticleIdList": ["10.2174/1566524017666170209160619", "28190385"]}, {"Citation": "Wang P., Henning S.M., Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS ONE. 2010;5:e10202. doi: 10.1371/journal.pone.0010202.", "ArticleIdList": ["10.1371/journal.pone.0010202", "PMC2855713", "20419137"]}, {"Citation": "Yoon S.J., Kim S.K., Lee N.Y., Choi Y.R., Kim H.S., Gupta H., Youn G.S., Sung H., Shin M.J., Suk K.T. Effect of Korean Red Ginseng on metabolic syndrome. J. Ginseng Res. 2020;45:380\u2013389. doi: 10.1016/j.jgr.2020.11.002.", "ArticleIdList": ["10.1016/j.jgr.2020.11.002", "PMC8134847", "34025131"]}, {"Citation": "Chen J.-Q., Cammarata P.R., Baines C.P., Yager J.D. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim. Biophys. Acta BBA Bioenerg. 2009;1793:1540\u20131570. doi: 10.1016/j.bbamcr.2009.06.001.", "ArticleIdList": ["10.1016/j.bbamcr.2009.06.001", "PMC2744640", "19559056"]}, {"Citation": "Hou N., Liu N., Han J., Yan Y., Li J. Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells. Anti-Cancer Drugs. 2017;28:59\u201365. doi: 10.1097/CAD.0000000000000430.", "ArticleIdList": ["10.1097/CAD.0000000000000430", "27603595"]}, {"Citation": "Pandey P., Sayyed U., Tiwari R.K., Siddiqui M.H., Pathak N., Bajpai P. Hesperidin induces ROS-mediated apoptosis along with cell cycle arrest at G2/M phase in human gall bladder carcinoma. Nutr. Cancer. 2018;71:676\u2013687. doi: 10.1080/01635581.2018.1508732.", "ArticleIdList": ["10.1080/01635581.2018.1508732", "30265812"]}, {"Citation": "Zuo Z., Huang M., Kanfer I., Chow M.S.S., Cho W.C.S. Herb-drug interactions: Systematic review, mechanisms, and therapies. Evid.-Based Complement. Altern. Med. 2015;2015:239150. doi: 10.1155/2015/239150.", "ArticleIdList": ["10.1155/2015/239150", "PMC4352432", "25792995"]}, {"Citation": "Khamis A., Ali E.M., El-Moneim M.A.A., Abd-Alhaseeb M., Abu El-Magd M., Salim E.I. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Biomed. Pharmacother. 2018;105:1335\u20131343. doi: 10.1016/j.biopha.2018.06.105.", "ArticleIdList": ["10.1016/j.biopha.2018.06.105", "30021371"]}, {"Citation": "El-Sisi A.E., Sokkar S.S., Ibrahim H.A., Hamed M.F., Abu-Risha S.E. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity. Fundam. Clin. Pharmacol. 2020;34:458\u2013475. doi: 10.1111/fcp.12549.", "ArticleIdList": ["10.1111/fcp.12549", "32080901"]}, {"Citation": "Febriansah R., Dyaningtyas D.P., Sarmoko, Nurulita N.A., Meiyanto E., Nugroho A.E. Hesperidin as a preventive resistance agent in MCF\u20137 breast cancer cells line resistance to doxorubicin. Asian Pac. J. Trop. Biomed. 2014;4:228\u2013233. doi: 10.1016/S2221-1691(14)60236-7.", "ArticleIdList": ["10.1016/S2221-1691(14)60236-7", "PMC3868794", "25182442"]}, {"Citation": "Al-Rikabi R., Al-Shmgani H., Dewir Y.H., El-Hendawy S. In vivo and in vitro evaluation of the protective effects of hesperidin in lipopolysaccharide-induced inflammation and cytotoxicity of cell. Molecules. 2020;25:478. doi: 10.3390/molecules25030478.", "ArticleIdList": ["10.3390/molecules25030478", "PMC7038000", "31979178"]}, {"Citation": "Li Y., Li X., Cuiping C., Pu R., Weihua Y. Study on the anticancer effect of an astragaloside- and chlorogenic acid-containing herbal medicine (RLT-03) In breast cancer. Evid.-Based Complement. Altern. Med. 2020;2020:1515081. doi: 10.1155/2020/1515081.", "ArticleIdList": ["10.1155/2020/1515081", "PMC7305538", "32595723"]}, {"Citation": "Zeng A., Liang X., Zhu S., Liu C., Wang S., Zhang Q., Zhao J., Song L. Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-\u03baB signaling pathway. Oncol. Rep. 2021;45:717\u2013727. doi: 10.3892/or.2020.7891.", "ArticleIdList": ["10.3892/or.2020.7891", "PMC7757108", "33416150"]}, {"Citation": "Rosendahl A.H., Perks C., Zeng L., Markkula A., Simonsson M., Rose C., Ingvar C., Holly J.M., Jernstr\u00f6m H. Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer. Clin. Cancer Res. 2015;21:1877\u20131887. doi: 10.1158/1078-0432.CCR-14-1748.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-1748", "25691730"]}, {"Citation": "Cincin Z., Kiran B., Baran Y., Cakmakoglu B. Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells. Biomed. Pharmacother. 2018;103:336\u2013345. doi: 10.1016/j.biopha.2018.04.020.", "ArticleIdList": ["10.1016/j.biopha.2018.04.020", "29665555"]}, {"Citation": "Liu Y.-J., Zhou C.-Y., Qiu C.-H., Lu X.-M., Wang Y.-T. Chlorogenic acid induced apoptosis and inhibition of proliferation in human acute promyelocytic leukemia HL-60 cells. Mol. Med. Rep. 2013;8:1106\u20131110. doi: 10.3892/mmr.2013.1652.", "ArticleIdList": ["10.3892/mmr.2013.1652", "23982123"]}, {"Citation": "Rostoker R., Abelson S., Bitton-Worms K., Genkin I., Ben-Shmuel S., Dakwar M., Orr Z.S., Caspi A., Tzukerman M., LeRoith D. Highly specific role of the insulin receptor in breast cancer progression. Endocr. Relat. Cancer. 2015;22:145\u2013157. doi: 10.1530/ERC-14-0490.", "ArticleIdList": ["10.1530/ERC-14-0490", "PMC4362669", "25694511"]}, {"Citation": "Rose D.P., Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr.-Relat. Cancer. 2012;19:R225\u2013R241. doi: 10.1530/ERC-12-0203.", "ArticleIdList": ["10.1530/ERC-12-0203", "22936542"]}, {"Citation": "Wang R.-H., Zheng Y., Kim H.-S., Xu X., Cao L., Lahusen T., Lee M.-H., Xiao C., Vassilopoulos A., Chen W., et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis. Mol. Cell. 2008;32:11\u201320. doi: 10.1016/j.molcel.2008.09.011.", "ArticleIdList": ["10.1016/j.molcel.2008.09.011", "PMC2577018", "18851829"]}, {"Citation": "Shi L., Tang X., Qian M., Liu Z., Meng F., Fu L., Wang Z., Zhu W.-G., Huang J.-D., Zhou Z., et al. A SIRT1-centered circuitry regulates breast cancer stemness and metastasis. Oncogene. 2018;37:6299\u20136315. doi: 10.1038/s41388-018-0370-5.", "ArticleIdList": ["10.1038/s41388-018-0370-5", "PMC6283862", "30038266"]}, {"Citation": "Carafa V., Altucci L., Nebbioso A. Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Front. Pharmacol. 2019;10:38\u201351. doi: 10.3389/fphar.2019.00038.", "ArticleIdList": ["10.3389/fphar.2019.00038", "PMC6363704", "30761005"]}, {"Citation": "Battisti N.M.L., Tong D., Ring A., Smith I. Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience. Breast Cancer Res. Treat. 2019;178:401\u2013408. doi: 10.1007/s10549-019-05406-6.", "ArticleIdList": ["10.1007/s10549-019-05406-6", "31432365"]}, {"Citation": "Masoud V., Pag\u00e8s G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J. Clin. Oncol. 2017;8:120\u2013134. doi: 10.5306/wjco.v8.i2.120.", "ArticleIdList": ["10.5306/wjco.v8.i2.120", "PMC5385433", "28439493"]}, {"Citation": "Liyanage P.Y., Hettiarachchi S.D., Zhou Y., Ouhtit A., Seven E.S., Oztan C.Y., Celik E., Leblanc R.M. Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochim. Biophys. Acta BBA Bioenerg. 2019;1871:419\u2013433. doi: 10.1016/j.bbcan.2019.04.006.", "ArticleIdList": ["10.1016/j.bbcan.2019.04.006", "PMC6549504", "31034927"]}, {"Citation": "Dobrzynska M., Napierala M., Florek E. Flavonoid nanoparticles: A promising approach for cancer therapy. Biomolecules. 2020;10:1268. doi: 10.3390/biom10091268.", "ArticleIdList": ["10.3390/biom10091268", "PMC7564267", "32887473"]}, {"Citation": "Wang J., Li Q., Chen Z., Qi X., Wu X., Di G., Fan J., Guo C. Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudi-oside A nanomicelles system. Toxicol. Appl. Pharmacol. 2021;419:115511. doi: 10.1016/j.taap.2021.115511.", "ArticleIdList": ["10.1016/j.taap.2021.115511", "33819459"]}, {"Citation": "Sulaiman G.M., Waheeb H.M., Jabir M.S., Khazaal S.H., Dewir Y.H., Naidoo Y. Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model. Sci. Rep. 2020;10:1\u201316. doi: 10.1038/s41598-020-66419-6.", "ArticleIdList": ["10.1038/s41598-020-66419-6", "PMC7283242", "32518242"]}, {"Citation": "Lazer L.M., Sadhasivam B., Palaniyandi K., Muthuswamy T., Ramachandran I., Balakrishnan A., Pathak S., Narayan S., Ramalingam S. Chitosan-based nano-formulation enhances the anticancer efficacy of hesperetin. Int. J. Biol. Macromol. 2018;107:1988\u20131998. doi: 10.1016/j.ijbiomac.2017.10.064.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.10.064", "29032208"]}, {"Citation": "Rajan R.K., Hussein M.Z., Fakurazi S., Yusoff K., Masarudin M.J. Increased ROS scavenging and antioxidant efficiency of chlorogenic acid compound delivered via a chitosan nanoparticulate system for efficient in vitro visualization and accumulation in human renal adenocarcinoma cells. Int. J. Mol. Sci. 2019;20:4667. doi: 10.3390/ijms20194667.", "ArticleIdList": ["10.3390/ijms20194667", "PMC6801874", "31547100"]}, {"Citation": "Lin C.J., Chang L., Chu H.W., Lin H.J., Chang P.C., Wang R.Y., Unnikrishnan B., Mao J.-Y., Chen S.-Y., Huang C.-C. High amplification of the antiviral activity of curcumin through transformation into carbon quantum dots. Small. 2019;15:1902641. doi: 10.1002/smll.201902641.", "ArticleIdList": ["10.1002/smll.201902641", "31468672"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "6"}, {"Year": "2021", "Month": "9", "Day": "1"}, {"Year": "2021", "Month": "9", "Day": "6"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "1", "Minute": "14"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["34575098", "PMC8467139", "10.3390/life11090950", "life11090950"]}}], "PubmedBookArticle": []}